[Elsevier] Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study |
|
This post will be closed automatically in 2026-07-06 22:14
Reward20points
|
post
reply
points
2131
30
LANCET - Endocrine每neuropsychological interplay underpinning maternal postpartum depression
10
2025 ICM: Serological Diagnosis of Surgical Site Infection (SSI)/Periprosthetic Joint Infection (PJI)
20
A machine learning approach to identifying Salmonella stress response genes in isolates from poultry processing
20
The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
10
2025 ICM: Joint Aspiration
